Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain Yi ZhengXijing ChenLeslie Z. Benet Review Article 21 August 2015 Pages: 143 - 167
Alternative Sampling Strategies for Cytochrome P450 Phenotyping Pieter M. M. De KeselWilly E. LambertChristophe P. Stove Review Article 04 August 2015 Pages: 169 - 184
Challenges Associated with Route of Administration in Neonatal Drug Delivery Matthew W. LinakisJessica K. RobertsCatherine M. T. Sherwin Review Article 06 August 2015 Pages: 185 - 196
Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir Sivi Ouwerkerk-MahadevanJan SnoeysAlexandru Simion Review Article Open access 09 September 2015 Pages: 197 - 208
Population Pharmacokinetic Modeling of Canagliflozin in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus Eef HoebenWillem De WinterAdrian Dunne Original Research Article 21 August 2015 Pages: 209 - 223
Pharmacokinetics and Safety of Single Intravenous Doses of JNJ-54452840, an Anti-β1-Adrenergic Receptor Antibody Cyclopeptide, in Healthy Male Japanese and Caucasian Participants Ivo P. NnaneAlexei H. PlotnikovBrian E. Davies Original Research Article 05 August 2015 Pages: 225 - 236
Effects of Cytochrome P450 3A4 Inhibitors—Ketoconazole and Erythromycin—on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling Predictions Christophe BoetschNeil ParrottCarsten Hofmann Original Research Article 04 September 2015 Pages: 237 - 247
Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch Lisette BinkhorstMarjolein BanninkRon H. J. Mathijssen Original Research Article Open access 08 October 2015 Pages: 249 - 255